Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone safety study in active or treatment-resistant acromegaly
2007-005568-28Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rosiglitazone in acromegaly, sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoints: Safety and objective clinical assessment, Laboratory safety assessment and 1 more. Started Nov 2007; status: completed.
02
Drugs
rosiglitazone
03
Conditions
acromegaly
Beyond the preview
Go deeper on 2007-005568-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005568-28.